Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

Starting on July 1, Wegovy will become the preferred GLP-1 for obesity treatment on CVS Caremark’s largest commercial ...

Trump's Department of Commerce is looking into what it calls national security threats from overseas drug manufacturing, and Lilly CEO David Ricks has personally met with President Donald Trump in ...

Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its ...

Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and ...

Ricks said reshoring manufacturing capacity for older essential medicines is “a valid thing,” adding that Eli Lilly is “happy ...

Currently, 51 countries provide their citizens with some form of universal healthcare while Americans continue to struggle ...

A Tampa family celebrated their daughter's health milestone at the March of Dimes March for Babies walk. Lilly Lewellen spent ...

Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish ...

Health officials are poised to announce trials to significantly widen access to the revolutionary injections. They will allow ...

In its complaint against Fella Health, Lilly said the company made “sweeping corporate decisions that dictate patient care, such as when Fella changed patients en masse from one tirzepatide ...

Eli Lilly alleges Willow falsely claims its products are safe, effective and superior to its FDA-approved tirzepatide medicines, sold under Lilly's brand names: Mounjaro, which treats diabetes, and ...